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A B S T R A C T
Purpose: To report two cases of neurotrophic keratitis (NK) after micropulse transscleral cyclophotocoagulation
(MP-TCP).
Observations: Two patients with predisposing factors for decreased corneal sensation developed NK 1 month
after MP-TCP. Both patients did not heal with initial treatment with topical antibiotic and preservative free
artificial tears. One patient required use of a bandage contact lens and the other patient required tarsorrhaphy.
Both eyes experienced recurrence of NK.
Conclusions and importance: NK can be triggered after MP-TCP in patients with underlying predisposing factors
for decreased corneal sensation. This uncommon but vision-threatening complication should be discussed pre-
operatively with high-risk patients as a possible adverse event after MP-TCP and followed closely post-
operatively.
1. Introduction
Micropulse transscleral cyclophotocoagulation (MP-TCP) has been
recently incorporated in the range of options for treating glaucoma
after failure of medical treatment. With micropulse technology the
diode laser is delivered to the pars plana in a series of repetitive short
pulses of laser energy separated by rest periods. During the “ON period”
the laser energy is absorbed preferentially by the targeted pigmented
tissue, eventually reaching the coagulative threshold. While in the “OFF
period” the adjacent non-pigmented tissues are able to “cool off,”
thereby minimizing collateral tissue damage.1,2 The customized probe
contacts the sclera and moves in a continuous painting fashion rather
than individual burns.
MP-TCP has been reported to have similar success rates compared to
the traditional transscleral cyclophotocoagulation but with lower in-
cidence of complications.1 Although it has been suggested to have a
safer profile in comparison with traditional transcleral cyclophotocoa-
gulation (TCP), the following complications have been described with
MP-TCP: hypotony, intraocular pressure (IOP) spike, prolonged ante-
rior chamber inflammation, macular edema, corneal edema, phtisis
bulbi, and transient hyphema in cases with neovascular glaucoma.1–6
The aim of this case report is to present two cases of severe neuro-
trophic keratopathy (NK) after MP-TCP. To our knowledge, these post-
MP-TCP complications have not been previously described in the lit-
erature.
2. Findings
2.1. Case 1
Patient is a 79-year old Asian female, with history of poorly con-
trolled diabetes. Ocular history includes mixed mechanism glaucoma
status post laser peripheral iridotomy (LPI) in both eyes, proliferative
diabetic retinopathy with macular edema status post multiple in-
travitreal bevacizumab injections in both eyes, recurrent vitreous he-
morrhage status post pars plana vitrectomy, endolaser in both eyes,
lensectomy in right eye, and cataract surgery in left eye. Diabetic re-
tinopathy has been quiescent since 2009. Patient was on topical tra-
voprost, dorzolamide, timolol, and brimonidine in both eyes for her
glaucoma. Best corrected visual acuity was hand motion in the right eye
and 20/40 in the left eye preoperatively. IOP was 24mmHg on right
and 17mmHg on left. Slit lamp examination was notable for clear
cornea in both eyes, aphakia in the right eye, and pseudophakia in the
left eye. Optic nerve examination showed enlarged cup disc ratio with
inferior rim thinning and significant progression on the OCT. Visual
field was unreliable in the right eye due to poor central vision
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secondary to macular edema. Given uncontrolled intraocular pressure,
limited visual potential, and patient's desire to reduce eye drop burden,
we elected to proceed with MP-TCP in the right eye.
2.2. Case 2
Patient is a 79-year old Hispanic female with well-controlled hy-
pertension and diabetes mellitus without retinopathy. Ocular history
includes cataract surgery in both eyes, herpetic keratitis status post
penetrating keratoplasty in left eye, and advanced chronic angle closure
glaucoma in both eyes status post Ahmed valve implantation in both
eyes with subconjunctival adjunctive mitomycin-C over the plate at
postoperative week one and month one.7 Preoperative best corrected
visual acuity was 20/40 right eye and 20/150 left eye. Examination was
notable for superficial punctate keratitis in the right eye and clear and
compact corneal transplant in the left eye. Posterior examination was
notable for severe glaucomatous cupping with 0.9 cup-to-disc ratio both
eyes. Her IOP right eye was above goal in the high teens (16–22mmHg)
despite being on maximum tolerated medical therapy with timolol,
dorzolamide, and brimonidine. The decision was made to proceed with
MP-TCP in the right eye to better control the IOP with faster visual
recovery in this functionally monocular patient with advanced glau-
coma.
2.3. Surgical procedure
After general anesthesia was conducted, the G6 micropulse probe
(IRIDEX Inc., Mountain View, CA) was placed at the limbus with the
notch facing the limbus and the probe perpendicular to the surface of
the globe. Laser settings were 2000 mW with a duty cycle of 31.33%.
One hundred eighty degrees were treated by moving the probe in a
continuous painting fashion, over 80 seconds. The other hemifield was
then treated using the same procedure to achieve 360° of treatment.
Care was taken to avoid the 3 and 9 o'clock position. During the post-
operative period, prednisolone 1% was given 4 times a day with a
weekly taper over the first month.
3. Postoperative period
3.1. Case 1
At postoperative week 1, vision was counting fingers with an IOP of
8mmHg. Examination showed intact cornea epithelium without any
epithelial defect. At the 1-month postoperative visit, visual acuity re-
mained stable at counting fingers and IOP was 10mmHg on the same
preoperative glaucoma medications. Slit lamp examination of the right
eye showed mild conjunctival injection and a large epithelial defect
measuring 2 mm vertical x 6 mm horizontal (Fig. 1) in the inter-
palpebral region with heaped epithelial margins. Patient reported mild
discomfort but was otherwise asymptomatic. Corneal sensation was
reduced in all quadrants and no lagophthalmos was noted. The patient
was treated with Trimethoprim/polymyxin B eyedrops and preservative
free artificial tears plus lubricant ointment at night. Prednisolone was
discontinued. Two weeks later the corneal epithelial defect persisted
without improvement, thus a bandage contact lens was applied. The
corneal epithelial defect healed after two weeks of therapeutic bandage
contact lens wear (postoperative month 2).
The patient subsequently developed a recurrent epithelial defect at
postoperative month 3 and 5 that responded to topical antibiotic, lu-
brication, and bandage contact lens. She was given proper instruction
on eye drop administration and monitored frequently. At postoperative
month 7 her epithelium was intact and the IOP was 19mmHg in the
right eye with travatan at night and timolol 0.5% twice a day.
3.2. Case 2
At postoperative week 1, the IOP in the right eye was 6mmHg and
all glaucoma medications were discontinued. Atropine 1% was added
for shallow peripheral choroidal effusions.
At postoperative week 3, the patient presented with painless corneal
epithelial defect measuring 4.5 mm vertical x 7 mm horizontal with
rolled edges. Trimethoprim/polymyxin B eye drops were added along
with preservative free artificial tears. One week later, the corneal epi-
thelial defect persisted without improvement, thus a bandage contact
lens was placed. At postoperative week 5, the corneal epithelial defect
remained unchanged without improvement despite medical therapy.
Corneal sensation again was reduced in all quadrants suggesting NK.
Culture was obtained and was negative for infection. Given the lack of
improvement, the epithelial edges were scraped to promote healing and
a temporary lateral tarsorrhaphy was placed. The corneal epithelial
defect healed within 2 weeks.
At postoperative month 3.5, the patient developed a recurrence of
the epithelial defect, measuring 3 mm vertical x 5 mm horizontal. A
temporary lateral tarsorrhaphy was again performed.
At postoperative month 6, best corrected visual acuity of the right
eye was 20/70 and IOP was 9mmHg without medication.
Unfortunately, the corneal epithelial defect recurred despite a lateral
tarsorrhaphy at the area where the cornea was exposed. A contact
bandage lens was added and 1 week later the epithelial defect was
healed with epithelial irregularity in the zone of the previous defect
(Fig. 2). IOP in the right eye was 11mmHg without glaucoma medi-
cations.
4. Discussion
MP-TCP is an alternative form of cyclodestructive procedure in the
treatment of uncontrolled glaucoma. The delivery of diode laser is
fragmented into pulses, separated by rest periods, to minimize
Fig. 1. Slit lamp photography of the right eye of Patient 1 depicting a large epithelial defect stained with fluorescein in the interpalpebral zone with rolled epithelial
margins.
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collateral tissue damage.1,2 Compared to traditional TCP, MP-TCP has a
better safety profile with lower complication rates and can be used in
eyes with better visual potential. Corneal complication is uncommon
with two cases of corneal edema reported by Williams et al.3 Here we
present two patients who developed NK after MP-TCP.
NK is characterized by reduced corneal sensitivity, spontaneous
epithelial breakdown, and impairment of corneal healing despite fre-
quent lubrication.8 NK is often difficult to treat with a high rate of re-
currence of epithelial breakdown and may predispose patients to the
development of infectious corneal ulcers. Both patients presented in our
report had risk factors for decreased corneal sensation for many years
but never developed NK prior to the MP-TCP treatment. Another po-
tential confounder for the NK in patient 2 was the adjunctive mito-
mycin-C following the Ahmed valve implantation. However, we routi-
nely perform adjunctive mitomycin-C following Ahmed valve at our
institution and we have not seen a case of NK as reported previously.7
The temporal relationship of the events is highly suggestive that MP-
TCP was the inciting factor for the development of NK.
NK has been described previously after traditional TCP, but not with
MP-TCP.8,9 All cases described in the literature had predisposing con-
ditions for decreased corneal innervation. The risk factors described
among the published cases after traditional TCP were multiple prior
ocular surgeries with corneal incisions, poorly controlled diabetes with
neovascular glaucoma, chronic use of topical beta blockers, and corneal
dystrophies.8,9
The pathophysiology behind the development of NK after tradi-
tional TCP was thought to be related to the emitted diode laser dama-
ging the long ciliary nerves, thus it is important for the surgeon to avoid
ablating the 3 and 9 o'clock position where the long ciliary nerves in-
nervate the anterior segment. The ciliary nerves are responsible for
sensation and play a critical role in the blink reflex, tear production and
secretion, as well as the integrity and function of the corneal epithe-
lium. The neuropeptides are especially important in epithelial wound
healing.10 The thermal effect has been shown previously with tradi-
tional TCP, in which the continuous application of the diode laser
causes coagulative necrosis of the pigmented cells and adjacent tissue.11
However, there are no histologic studies evaluating corneal nerves after
TCP, although Raivio et al.12 showed no difference in the corneal sen-
sation and corneal nerves density after traditional TCP in eyes without
predisposing conditions that affects the corneal sensory nerves. Future
study can be considered to evaluate the corneal nerves density before
and after MP-TCP using confocoal microscopy.
Despite avoiding the 3 and 9 o'clock position during the MP-TCP
treatment, two patients still developed NK after MP-TCP. We hy-
pothesized that this may be due to thermal damage to the perilimbal
nerve plexus surrounding the corneal limbus.13 The custom probe for
the MP-TCP differs from the traditional TCP in that it has a curved
contact point rather than a wedged contact tip, and may lead to inad-
vertent ablation of the perilimbal nerve plexus during the treatment
with the probe being placed too anteriorly towards the cornea. Given
this concern, we advise to avoid any overlapping of the laser probe over
the corneal limbus to avoid the possibility of direct nerve damage.
Unlike traditional TCP where energy duration and amount are titrated
based on pigmentation, the laser energy for MP-TCP is standardized at
2000mW except for the treatment duration which may vary among
providers. Several treatment durations have been described for MP-
TCP, ranging from 100 to 360 seconds.2,3,5 Both of our patients received
160 seconds of MP-TCP, which is on the shorter duration. Thus, the NK
from our report is unlikely to be a complication of overtreatment.
Regarding the time of onset of the NK after traditional TCP, Johnson
SM.9 has described two cases in which the corneal epithelial defect was
detected at postoperative month one. Fernández-Vega González Á
et al.9 reported five cases of NK after traditional TCP in which the mean
time for diagnosing the epithelial defect was at 22 days (range: 10–35
days). Classically, the neurotrophic ulcer does not present with pain, so
the onset may be difficult to determine. Our patients had a similar
presentation and onset time of these prior NK case reports described in
the literature after traditional TCP. Both patients presented during their
regular follow up at 3 or 4 weeks after the MP-TCP with asymptomatic
large corneal epithelial defect. Given the improved safety profile com-
pared to traditional TPC,1 MP-TCP has been utilized in eyes with better
visual potential.14 Thus, it is important to identify at risk patients,
particularly those with conditions that alter corneal sensory nerves,8
and to counsel them of the potential risk of developing postoperative
NK and to follow closely in the initial postoperative period.
Treatment for NK has a step-ladder approach depending on the
stage and severity of the disease.8,10 As presented in our patients, initial
treatment includes preservative free artificial tears, topical antibiotics
to prevent infection, and bandage contact lens to improve epitheliali-
zation. Nevertheless, many patients needed additional treatment such
as debridement of the rolled edges of the epithelial defect, autologous
serum eye drops, amniotic membrane, tarsorrhaphy, and others.8,10
Average healing time for epithelial defects is around 36 days with high
recurrence rate.9
5. Conclusions
NK is a rare but serious complication that can develop after MP-TCP
in patients with predisposing factors for decreased corneal sensation.
The treatment of NK can be difficult and carries a high rate of recur-
rence. The risk of developing NK should be discussed preoperatively
with high-risk patients and patients should be monitored closely post-
operatively. When performing the laser, care should be taken to avoid
treating the 3 and 9 o'clock position, and consideration should avoid
placing the probe too anteriorly to the limbus. Future studies should
evaluate prospectively the utility of measuring corneal sensation,
quantifying corneal nerves using confocal microscopy before and after
MP-TCP, and determining optimum probe placement.
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Fig. 2. Right eye slit lamp photo of temporal tarsorraphy with central corneal
epithelium irregularity in the zone of the recurrent epithelial defect due to
neurotrophic keratitis.
C.I. Perez, et al. American Journal of Ophthalmology Case Reports 15 (2019) 100469
3
Authorship
All authors attest that they meet the current ICMJE criteria for
Authorship.
Acknowledgements
Dr. Claudio Perez acknowledges the Pan-American
Ophthalmological Foundation and the Retina Research Foundation for
funding through the Gillingham Pan-American Fellowship.
This work was made possible in part, by NIH-NEI EY002162 - Core
Grant for Vision Research and by the Research to Prevent Blindness
Unrestricted Grant.
Appendix A. Supplementary data
Supplementary data to this chapter can be found online at https://
doi.org/10.1016/j.ajoc.2019.100469.
References
1. Aquino MC, Barton K, Tan AM, et al. Micropulse versus continuous wave transscleral
diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory
study. Clin Exp Ophthalmol. 2015;43(1):40–46.
2. Tan AM, Chockalingam M, Aquino MC, et al. Micropulse transscleral diode laser
cyclophotocoagulation in the treatment of refractory glaucoma. Clin Exp Ophthalmol.
2010;38(3):266–272.
3. Williams AL, Moster MR, Rahmatnejad K, et al. Clinical efficacy and safety profile of
micropulse transscleral cyclophotocoagulation in refractory glaucoma. J Glaucoma.
2018;27(5):445–449.
4. Emanuel ME, Grover DS, Fellman RL, et al. Micropulse cyclophotocoagulation: initial
results in refractory glaucoma. J Glaucoma. 2017;26(8):726–729.
5. Lee JH, Shi Y, Amoozgar B, et al. Outcome of micropulse laser transscleral cyclo-
photocoagulation on pediatric versus adult glaucoma patients. J Glaucoma.
2017;26(10):936–939.
6. Kuchar S, Moster MR, Reamer CB, et al. Treatment outcomes of micropulse trans-
cleral cyclophotocoagulation in advanced glaucoma. Lasers Med Sci.
2016;31(2):393–396.
7. Alvarado JA, Hollander DA, Juster RP, Lee LC. Ahmed valve implantation with ad-
junctive mitomycin C and 5-fluorouracil: long-term outcomes. Am J Ophthalmol. 2008
Aug;146(2):276–284.
8. Johnson SM. Neurotrophic corneal defects after diode laser cycloablation. Am J
Ophthalmol. 1998;126(5):725–727.
9. Fernández-Vega González Á, Barraquer Compte RI, Cárcamo Martínez AL, et al.
Neurotrophic keratitis after transscleral diode laser cyclophotocoagulation. Arch Soc
Esp Oftalmol. 2016;91(7):320–326.
10. Dua HS, Messmer EM, Rolando M, et al. Neuropathic keratopathy. Prog Retin Eye Res.
2018 Sep;66:107–131 [Epub ahead of print].
11. Lin SC, Chen MJ, Lin MS, et al. Vascular effects on ciliary tissue from endoscopic
versus scleral cyclophotocoagulation. Br J Ophthalmol. 2006;90(4):496–500.
12. Raivio VE, Vesaluoma MH, Tervo TM, et al. Corneal innervation, corneal mechanical
sensitivity, and tear fluid secretion after transscleral contact 670-nm diode laser
cyclophotocoagulation. J Glaucoma. 2002;11(5):446–453.
13. Shaheen BS, Bakir M, Jain S. Corneal nerves in health and disease. Surv Ophthalmol.
2014 May-Jun;59(3):263–285.
14. Masis Solano M, Huang G, Lin SC. When should we give up filtration surgery: in-
dications, techniques and results of cyclodestruction. Dev Ophthalmol.
2017;59:179–190.
C.I. Perez, et al. American Journal of Ophthalmology Case Reports 15 (2019) 100469
4
